TRTCanada.ca

How hard is it to get TRT in Canada?

The hard part is the blood test, not the appointment. Canadian and international guidelines ask a prescriber for symptoms plus a low morning total testosterone confirmed on repeat testing before starting testosterone replacement therapy (TRT); the Canadian Urological Association calls a total below 10 nmol/L a reasonable threshold. A man who meets that is prescribed in primary care, by nurse practitioners and by online services alike. A man whose level is normal is declined by any prescriber following the guidelines. Seeing a prescriber at all is harder in some provinces than others: in 2023, between 73 and 88 percent of adults had a regular health care provider, depending on the province.

Who can prescribe testosterone

Testosterone is a controlled drug, so the prescriber must be a practitioner under federal law. Physicians qualify everywhere. Nurse practitioners have been permitted to prescribe testosterone since the New Classes of Practitioners Regulations of 2012, where their province authorizes it, and the Controlled Substances Regulations in force from 1 October 2026 keep nurse practitioners as practitioners while barring midwives and podiatrists from anabolic steroids, testosterone included. The colleges in British Columbia, Alberta, Saskatchewan, Manitoba, Ontario and New Brunswick publish nurse practitioner standards that cover testosterone, usually after a required controlled-substances course. Health Canada states that the federal regulations do not permit pharmacists to prescribe controlled substances; since 1 October 2026 a pharmacist may extend or adapt an existing prescription within limits, but not write a new one. No province read for this page restricts testosterone to specialists. The province-by-province detail is on the who can prescribe testosterone page.

What a prescriber needs first

The Canadian Urological Association's 2021 guideline states that total testosterone from a morning draw, 7 to 11 a.m., "remains the best initial screening test," that a total below 10 nmol/L "represents a reasonable diagnostic threshold," and that the diagnosis rests on history, physical examination and laboratory results together. The Endocrine Society's 2018 guideline asks for "unequivocally and consistently low" total testosterone plus symptoms, with the diagnosis confirmed by repeating the morning fasting measurement. Choosing Wisely Canada's endocrinology list, updated April 2026, says: "Don't prescribe testosterone therapy unless there is biochemical evidence of testosterone deficiency," and its urology list, updated July 2025, adds: "Don't order serum testosterone in men without symptoms of hypogonadism" and "Don't prescribe testosterone to men with erectile dysfunction who have normal testosterone levels."

The May 2025 Canadian Family Physician review by Moe and Potter, which many family doctors read, summarizes the trials this way: testosterone may add about 1.6 kg of lean mass in older men but has no consistent, meaningful effect on sexual function, strength, fatigue or cognition, does not increase prostate events, heart attack or stroke, and may increase pulmonary embolism and atrial fibrillation. A doctor who has read it will want a confirmed low level before prescribing. What the tests are, how they are timed and what they cost is on the testosterone testing page; the guideline thresholds in nmol/L and ng/dL are on the testosterone levels page.

A symptom questionnaire does not replace any of this. The Canadian Urological Association states that screening questionnaires alone should not be substituted for a detailed history, physical examination and laboratory testing, and the ADAM questionnaire's own validation study reported 88 percent sensitivity and 60 percent specificity, which means it flags many men whose testosterone is normal.

Finding a prescriber

In 2023, 82.8 percent of Canadian adults had a regular health care provider: 87.6 percent in Ontario, 85.4 percent in Alberta, 84.9 percent in Manitoba, 79.2 percent in Nova Scotia, 78.1 percent in Newfoundland and Labrador, 74.2 percent in Quebec and 73.1 percent in Prince Edward Island (Statistics Canada, Canadian Community Health Survey, released 5 March 2025). CIHI's figure for 2024, updated June 2026, is 82.6 percent nationally. Every province except Saskatchewan runs a registry for people without a provider:

Provincial registries for finding a family doctor or nurse practitioner, names confirmed 8 October 2026. Each province's guide gives the link and the health advice line.
ProvinceRegistry
British ColumbiaHealth Connect Registry (HealthLink BC)
AlbertaAlberta Find a Provider (Primary Care Alberta)
SaskatchewanNo provincial registry; HealthLine 811
ManitobaFamily Doctor Finder
OntarioHealth Care Connect
QuebecPrimary Care Access Point (GAP)
New BrunswickPatient Connect NB
Nova ScotiaNeed a Family Practice Registry
Prince Edward IslandPatient Registry Program
Newfoundland and LabradorPatient Connect NL

Specialist referral is not usually needed. For those who are referred, Statistics Canada's 2024 Survey on Health Care Access and Experiences found that 36 percent of people needing an initial specialist consultation waited three months or more; the survey does not separate endocrinology or urology. Online services shorten the wait to a prescriber but apply the same laboratory criteria; what each one states about its process is in the providers table, and what each province's public route looks like is on the access by province page.

Why a clinician may decline

The reasons in the guidelines and the Canadian product label are specific. The Canadian Urological Association lists known or suspected breast cancer and unstable cardiovascular disease as contraindications, says men who want fertility "should be cautioned against the isolated use of exogenous testosterone," asks that reversible causes such as sleep apnea be managed first, and sets a hematocrit of 55 percent or more as the point for action. The Endocrine Society recommends against therapy in men planning fertility in the near term, men with breast or prostate cancer, a palpable prostate nodule, a PSA above 4 ng/mL, an elevated hematocrit, untreated severe obstructive sleep apnea, severe lower urinary tract symptoms, uncontrolled heart failure, a heart attack or stroke within six months, or thrombophilia. The Taro testosterone cypionate monograph, revised 26 May 2022, states that androgens are contraindicated in men with known or suspected carcinoma of the prostate or breast, that hemoglobin and hematocrit should be checked periodically, that treatment may worsen sleep apnea, and that testosterone may increase blood pressure.

None of these is a judgement about the person asking. They are the conditions under which the evidence for benefit was gathered and the conditions under which harm was recorded. What the trials found, for and against, is in the evidence guides.

Common questions

How hard is it to get TRT in Canada?

It depends less on the clinic and more on the blood test. Canadian and international guidelines ask a prescriber for symptoms plus a low morning total testosterone confirmed on repeat testing before treatment; the Canadian Urological Association calls a total below 10 nmol/L a reasonable threshold. A man who meets that is prescribed by family doctors, nurse practitioners and online services alike. A man whose level is in the normal range is declined by any prescriber following the guidelines, and Choosing Wisely Canada tells urologists not to prescribe testosterone to men with erectile dysfunction who have normal levels.

Can I just ask my family doctor for TRT?

Yes. Any physician can prescribe testosterone in Canada, and no province read for this page restricts it to specialists. The doctor will usually order a morning blood test first and repeat a low result before prescribing, because the guidelines and the product labels describe treatment for confirmed deficiency. If you have no regular provider, every province except Saskatchewan runs a registry for finding one; the names are listed on this page.

Do nurse practitioners prescribe testosterone in Canada?

Yes, where the province authorizes it. Federal regulations have allowed nurse practitioners to prescribe testosterone since 2012, and the Controlled Substances Regulations in force from 1 October 2026 keep nurse practitioners as practitioners while excluding midwives and podiatrists from anabolic steroids. Provincial colleges in British Columbia, Alberta, Saskatchewan, Manitoba, Ontario and New Brunswick publish nurse practitioner controlled-drug prescribing standards that include testosterone, usually after a required course. Pharmacists cannot initiate a prescription for a controlled substance in any province.

Why would a doctor refuse to prescribe testosterone?

The usual reasons come from the guidelines and the product label: a testosterone level that is not low on a properly timed test; a planned pregnancy, because testosterone suppresses sperm production; known or suspected prostate or breast cancer; a high hematocrit; untreated severe sleep apnea; unstable heart disease or a recent heart attack or stroke; or a reversible cause that should be treated first. The Endocrine Society also recommends against therapy with a PSA above 4 ng/mL or a palpable prostate nodule without urological evaluation.

How long does it take to see a specialist?

In the 2024 Survey on Health Care Access and Experiences, 36 percent of Canadians who needed an initial specialist consultation waited three months or more. The survey does not break out endocrinology or urology, and most testosterone prescriptions in Canada are written in primary care without a referral.

What should I bring to a first appointment about low testosterone?

The guidelines base a diagnosis on history, physical examination and laboratory results together. Useful things to bring: any previous blood results, a list of current medications and supplements, a note of symptoms and when they started, sleep history, and whether you plan to have children. MyHealth Alberta notes that a doctor may want a morning blood test because testosterone is highest between 7 and 9 a.m. The questions worth asking are on the assessment page.

Published by
TRTCanada.ca.
Published
8 October 2026
Last reviewed
8 October 2026
Next check
19 October 2026

Sources

  1. Canadian Urological Association guideline on testosterone deficiency (Grober 2021), Canadian Urological Association Journal 15(5):E234-43. Source date 1 May 2021. Checked 8 October 2026.
  2. Testosterone therapy in men with hypogonadism, clinical practice guideline (Bhasin 2018), Endocrine Society. Source date 1 May 2018. Checked 8 October 2026.
  3. Testosterone supplementation for men (Moe, Potter 2025), Canadian Family Physician 71:321. Source date 1 May 2025. Checked 8 October 2026.
  4. Urology recommendations, Choosing Wisely Canada. Source date 1 July 2025. Checked 8 October 2026.
  5. Endocrinology and metabolism recommendations, Choosing Wisely Canada. Source date 1 April 2026. Checked 8 October 2026.
  6. Controlled Drugs and Substances Act, section 2, definition of practitioner, Justice Laws Canada. Consolidation current to 19 January 2026. Checked 8 October 2026.
  7. Controlled Substances Regulations (SOR/2025-242), sections 1, 153 and 154, Justice Laws Canada. In force 1 October 2026. Checked 8 October 2026.
  8. New Classes of Practitioners Regulations (SOR/2012-230), Justice Laws Canada. Consolidation current to 10 December 2025. Checked 8 October 2026.
  9. Prescription management by pharmacists of controlled substances, Health Canada. Source date 5 October 2023. Checked 8 October 2026.
  10. Nurse practitioner practice FAQs, College of Nurses of Ontario. Source date 6 October 2026. Checked 8 October 2026.
  11. Prescribing limits and conditions for nurse practitioners, BC College of Nurses and Midwives. No date shown on the page. Checked 8 October 2026.
  12. Prescribing controlled drugs and substances resource, College of Registered Nurses of Saskatchewan. Effective 1 October 2026. Checked 8 October 2026.
  13. Primary health care providers, 2023 (Canadian Community Health Survey), Statistics Canada. Source date 5 March 2025. Checked 8 October 2026.
  14. Canadians with a regular health care provider, 2024, Canadian Institute for Health Information. Source date 1 June 2026. Checked 8 October 2026.
  15. Survey on Health Care Access and Experiences, 2024: wait times for specialist consultations, Statistics Canada. Source date 29 July 2025. Checked 8 October 2026.
  16. Testosterone test, MyHealth Alberta. Source date 10 September 2024. Checked 8 October 2026.
  17. Validation of a screening questionnaire for androgen deficiency in aging males (Morley 2000), Metabolism 49(9):1239-1242. Source date 1 September 2000. Checked 8 October 2026.
  18. Taro-Testosterone Cypionate Injection, product monograph, Taro Pharmaceuticals, via Health Canada. Source date 26 May 2022. Checked 8 October 2026.